Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

Phase 1 Completed 112 enrolled Tanabe Pharma America, Inc.

Non-randomizedSequentialOpen-labelOther

Summary

Study is to investigate drug levels in the blood after taking single or multiple doses of the study drug, MT-7117, in healthy adults when taken together with another drug. This study will also look at the safety and the body's ability to tolerate MT-7117

Timeline

Start: 2021-03-23
Primary completion: 2022-02-04
Completion: 2022-02-04

Publications

Ogasawara A, Ide R, Inoue S, Tsuda M, Teng R. Assessment of Potential Drug-Drug Interactions for Novel Oral Melanocortin-1 Receptor Agonist Dersimelagon. Pharmacol Res Perspect. 2025 Feb;13(1):e70069. doi: 10.1002/prp2.70069.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dersimelagon	Small molecule	100 mg	Oral
Subject	Dersimelagon	Small molecule	300 mg	Oral

Indications

No indication recorded.